FCGR2A and cardiovascular disorder: Indeed, CRP also targets neutrophils, platelets, or other tissue-resident CD32+ cell types that may be relevant to cardiovascular diseases (such as endothelial cells, cardiomyocytes, or fibroblasts that were not explored in our study).